Wednesday, March 27, 2013

3 Small Cap Biopharmas Primed To Move Much Higher Now - Seeking Alpha

3 Small Cap Biopharmas Primed To Move Much Higher Now - Seeking Alpha
Posted by at No comments:

Tuesday, March 26, 2013

$AVEO Due Diligence: Catalyst: Adcomm May 2nd | StockMatusow.com

$AVEO Due Diligence: Catalyst: Adcomm May 2nd | StockMatusow.com
Posted by at No comments:

Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors - Seeking Alpha

Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors - Seeking Alpha
Posted by at No comments:

Thursday, March 21, 2013

Obagi Medical Products Acquired, These Biotechs May Be Next | Investing.com

Obagi Medical Products Acquired, These Biotechs May Be Next | Investing.com
Posted by at No comments:

Tuesday, March 19, 2013

AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar - Seeking Alpha

AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar - Seeking Alpha
Posted by at No comments:

Monday, March 18, 2013

AcelRx Pharmaceuticals Given New $7.00 Price Target at Guggenheim (ACRX) – Mideast Time

AcelRx Pharmaceuticals Given New $7.00 Price Target at Guggenheim (ACRX) – Mideast Time
Posted by at No comments:

Sunday, March 17, 2013

Significant catalysts and an unfortunate PR mistake present an opportunity in AcelRx Pharmaceuticals. | StockMatusow.com

Significant catalysts and an unfortunate PR mistake present an opportunity in AcelRx Pharmaceuticals. | StockMatusow.com
Posted by at No comments:

Significant catalysts and an unfortunate PR mistake present an opportunity in AcelRx Pharmaceuticals. | StockMatusow.com

Significant catalysts and an unfortunate PR mistake present an opportunity in AcelRx Pharmaceuticals. | StockMatusow.com
Posted by at No comments:

Significant Catalysts And Company PR Error Present Significant Opportunity In AcelRx Pharmaceuticals

Significant Catalysts And Company PR Error Present Significant Opportunity In AcelRx Pharmaceuticals
Posted by at No comments:

Friday, March 15, 2013

AcelRx Pharma Selloff Caused By Error In Recent Press Release | StockMatusow.com

AcelRx Pharma Selloff Caused By Error In Recent Press Release | StockMatusow.com
Posted by at No comments:

Tuesday, March 5, 2013

Trius Therapeutics: New MSRA Treatment Could Bring Billions In Revenues - Seeking Alpha

Trius Therapeutics: New MSRA Treatment Could Bring Billions In Revenues - Seeking Alpha
Posted by at No comments:

Download $TSRX Analyst Report | StockMatusow.com

Download $TSRX Analyst Report | StockMatusow.com
Posted by at No comments:
Subscribe to: Posts (Atom)